Insider Transactions in Q4 2019 at Cvs Health Corp (CVS)
Insider Transaction List (Q4 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2019
|
Karen S Lynch President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,778
-18.25%
|
$958,350
$75.55 P/Share
|
|
Nov 20
2019
|
Mary L Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
775
+29.12%
|
$57,350
$74.92 P/Share
|
|
Nov 20
2019
|
Fernando Aguirre Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,551
+7.2%
|
$114,774
$74.92 P/Share
|
|
Nov 20
2019
|
Mark T Bertolini Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,551
+10.12%
|
$114,774
$74.92 P/Share
|
|
Nov 20
2019
|
Richard M Bracken Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,626
+9.58%
|
$120,324
$74.92 P/Share
|
|
Nov 20
2019
|
C David Brown Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,651
+1.41%
|
$122,174
$74.92 P/Share
|
|
Nov 20
2019
|
Nancy Ann Deparle Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,626
+9.05%
|
$120,324
$74.92 P/Share
|
|
Nov 20
2019
|
David W Dorman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,904
+2.88%
|
$288,896
$74.92 P/Share
|
|
Nov 20
2019
|
Anne A. Finucane Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,551
+50.0%
|
$114,774
$74.92 P/Share
|
|
Nov 20
2019
|
Edward J Ludwig Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,626
+12.55%
|
$120,324
$74.92 P/Share
|
|
Nov 20
2019
|
Jean Pierre Millon Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,551
+50.0%
|
$114,774
$74.92 P/Share
|
|
Nov 20
2019
|
Richard J Swift Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,676
+18.6%
|
$124,024
$74.92 P/Share
|
|
Nov 20
2019
|
Tony L White Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,551
+4.73%
|
$114,774
$74.92 P/Share
|
|
Nov 18
2019
|
Karen S Lynch President and CEO |
SELL
Open market or private sale
|
Direct |
80,143
-65.71%
|
$6,010,725
$75.0 P/Share
|
|
Nov 04
2019
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
23,604
-21.87%
|
$1,605,072
$68.0 P/Share
|
|
Nov 04
2019
|
Troyen A Brennan EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,604
+17.95%
|
$1,274,616
$54.53 P/Share
|